Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta-analysis
- PMID: 36934438
- DOI: 10.1002/alz.13040
Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta-analysis
Abstract
Introduction: This systematic review evaluates the accuracy of the Montreal Cognitive Assessment (MoCA) for detecting mild cognitive impairment (MCI).
Methods: We searched MEDLINE, PSYCInfo, EMBASE, and Cochrane CENTRAL (1995-2021) for studies comparing the MoCA with validated diagnostic criteria to identify MCI in general practice. Screening, data extraction, and risk of bias assessment were performed independently, in duplicate. Pooled sensitivity and specificity for MoCA cutoffs were estimated using bivariate meta-analysis.
Results: Thirteen studies [2158 participants, 948(44%) with MCI] were included; 10 used Petersen criteria as the reference standard. Risk of bias of studies were high or unclear for all domains except reference standard. Sensitivity and specificity were 73.5%(95% confidence interval: 56.7-85.5) and 91.3%(84.6-95.3) at cutoff <23; 79.5%(67.1-88.0) and 83.7%(75.4-89.6) at cutoff <24; and 83.8%(75.6-89.6) and 70.8(62.1-78.3) at cutoff <25.
Discussion: MoCA cutoffs <23 to <25 maximized the sum of sensitivity and specificity for detecting MCI. The risk of bias of included studies limits confidence in these findings.
Keywords: Montreal Cognitive Assessment tool; accuracy; mild cognitive impairment; mild neurocognitive disorder; screening.
© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
References
REFERENCES
-
- Britt WG III, Hansen AM, Bhaskerrao S, et al. Mild cognitive impairment: prodromal Alzheimer's disease or something else? J Alzheimer's Dis. 2011;27(3):543-551. https://doi.org/10.3233/JAD-2011-110740
-
- Petersen RC. Mild cognitive impairment. Continuum (Minneap Minn). 2016;22:404-418. 2 Dementia. https://doi.org/10.1212/CON.0000000000000313
-
- Sabbagh MN, Boada M, Borson S, et al. Rationale for early diagnosis of mild cognitive impairment (MCI) supported by emerging digital technologies. J Prev Alzheimers Dis. 2020;7(3):158-164. doi: 10.14283/jpad.2020.19
-
- Morley JE. Anticholinergic medications and cognition. J Am Med Dir Assoc. 2011;12(8):543-543. e1. https://doi.org/10.1016/j.jamda.2011.07.008
-
- Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA. 2014;312(23):2551-2561. https://doi.org/10.1001/jama.2014.13806
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
